Nimodipine Increases CSF Somatostatin in Affectively Ill Patients

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Neuropsychopharmacology

• Publication date

  1995-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/0893-133X(95)00024-8PMID 8526973
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Huntington's chorea—Measurements of somatostatin, substance P and Cyclic nucleotides in the cerebrospinal fluid

  2004cited by this paper
• Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus

  2004cited by this paper
• Use of single case analyses in off-on-off-on trials in affective illness: A demonstration of the efficacy of nimodipine

  1994cited by this paper
• Molecular basis for somatostatin action: inhibition of c-fos expression and AP-1 binding.

  1994cited by this paper
• Calcium Channel Blockers Verapamil and Nimodipine Inhibit Kindling in Adult and Immature Rats

  1994cited by this paper
• Calcium antagonists in manic-depressive illness.

  1993cited by this paper
• Preliminary controlled trial of nimodipine in ultra-rapid cycling affective dysregulation.

  1993cited by this paper
• General Aspects of the Biology and Function of Somatostatin

  1992cited by this paper
• Calcium Antagonist Nimodipine in Intractable Epilepsy

  1992cited by this paper
• Functional changes in neuropeptide Y- and somatostatin-containing neurons induced by limbic seizures in the rat.

  1992cited by this paper
• Somatostatin in Alzheimer's disease and depression.

  1992cited by this paper
• CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression.

  1991cited by this paper
• Alterations in somatostatin and proenkephalin mRNA in response to a single amygdaloid stimulation versus kindling.

  1991cited by this paper
• Nimodipine in refractory epilepsy: a placebo-controlled, add-on study.

  1991cited by this paper
• Somatostatin inhibition of hormone release: effects on cytosolic Ca++ and interference with distal secretory events.

  1990cited by this paper
• Open trial of a calcium antagonist, nimodipine, in acute mania.

  1990cited by this paper
• The duration, nature and recurrence rate of brief depressions.

  1990cited by this paper
• Effects of the dihydropyridine Ca2+ channel antagonist nimodipine on kainic acid-induced limbic seizures.

  1990cited by this paper
• Short-term effects of the calcium channel blocker nimodipine (Bay-e-9736) in the management of primary degenerative dementia.

  1990cited by this paper
• Recurrent brief depression: a new subtype of affective disorder.

  1990cited by this paper
• Nimodipine and the recovery of memory.

  1990cited by this paper
• Placebo-controlled trial of nimodipine in the treatment of acute ischemic cerebral infarction.

  1990cited by this paper
• Nimodipine

  1989cited by this paper
• Cerebrospinal fluid somatostatin in delirium

  1989cited by this paper
• Selective depression of GABA-mediated IPSPs by somatostatin in area CA1 of rabbit hippocampal slices.

  1989cited by this paper
• Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial.

  1989cited by this paper
• Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVA.

  1989cited by this paper
• Concentrations of mRNAs encoding for preprosomatostatin and preprocholecystokinin are increased after kainic acid‐induced seizures

  1989cited by this paper
• Amygdaloid kindling of rats increases preprosomatostatin mRNA and somatostatin without affecting glutamic acid decarboxylase (GAD) mRNA or GAD.

  1989cited by this paper
• Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage.

  1988cited by this paper
• Concomitant increase of somatostatin, neuropeptide Y and glutamate decarboxylase in the frontal cortex of rats with decreased seizure threshold.

  1988cited by this paper
• Somatostatin in neuropsychiatric disorders.

  1988cited by this paper
• Intrathecal nimodipine therapy in a primate model of chronic cerebral vasospasm.

  1988cited by this paper
• Cerebrospinal fluid somatostatin correlates with spectral EEG variables and with parietotemporal cognitive dysfunction in Alzheimer patients.

  1988cited by this paper
• Further studies of the effects of somatostatin and related peptides in area CA1 of rabbit hippocampus

  1988cited by this paper
• Anticonvulsant profile of the dihydropyridine calcium channel antagonists, nitrendipine and nimodipine.

  1988cited by this paper
• Control of epilepsy partialis continuans with intravenous nimodipine. Report of two cases.

  1988cited by this paper
• Vascular effects of calcium antagonists. Uses in some cerebrovascular disorders.

  1988cited by this paper
• Effect of various calcium channel blockers on three different models of limbic seizures in rats.

  1988cited by this paper
• Nimodipine and neural plasticity in the peripheral nervous system of adult and aged rats

  1988cited by this paper
• Neuroactive Substances in Cerebrospinal Fluid

  1988cited by this paper
• CSF somatostatin in Alzheimer's disease, depressed patients, and control subjects.

  1988cited by this paper
• Effect of nimodipine upon electroencephalographic vigilance in elderly persons with minor impairment of brain functions.

  1988cited by this paper
• Effect of pentylenetetrazol-induced convulsions on somatostatin-like immunoreactivity in rat cerebrospinal fluid.

  1987cited by this paper
• CSF somatostatin in multiple sclerosis

  1987cited by this paper
• Suppression of Pentylenetetrazole Seizures by Oral Administration of a Dihydropyridine Ca2+ Antagonist

  1987cited by this paper
• Somatostatin content and release measured in cerebral biopsies from demented patients.

  1987cited by this paper
• Efficacy, Side Effects and Tolerance Compared During Headache Treatment With Three Different Calcium Blockers

  1987cited by this paper
• CSF somatostatin in patients with Alzheimer's disease, older depressed patients, and age-matched control subjects.

  1987cited by this paper
• Somatostatin augments the spread of limbic seizures from the hippocampus

  1987cited by this paper
• Somatostatin-like immunoreactivity and acetylcholinesterase activities in cerebrospinal fluid of patients with Alzheimer disease and senile dementia of the Alzheimer type.

  1986cited by this paper
• Electrical stimulation of several limbic areas suppressed the growth hormone (GH) release induced by human pancreatic GH-releasing factor in pentobarbital-anesthetized rats.

  1986cited by this paper
• Carbamazepine lowering effect on CSF somatostatin‐like immunoreactivity in temporal lobe epileptics

  1986cited by this paper
• Beta-endorphin and somatostatin concentrations in the ventricular cerebrospinal fluid of patients with affective disorder.

  1986cited by this paper
• Cerebrospinal fluid somatostatin and psychiatric illness.

  1986cited by this paper
• Trophic effects of somatostatin on calcium flux: dynamic analysis and correlation with pituitary hormone release.

  1986cited by this paper
• CSF somatostatin‐like immunoreactivity in dementia

  1986cited by this paper
• Somatostatin in the central nervous system: physiology and pathological modifications.

  1986cited by this paper
• Inhibition of electrically induced seizures by a dihydropyridine calcium channel blocker.

  1986cited by this paper
• A guanine nucleotide-binding protein mediates the inhibition of voltage-dependent calcium current by somatostatin in a pituitary cell line.

  1986cited by this paper
• A Study of Somatostatin Receptors in Amygdaloid‐Kindled Rat Brain

  1985cited by this paper
• Evaluation of an analogue of somatostatin (L363,586) in Alzheimer's disease.

  1985cited by this paper
• Involvement of hypothalamic somatostatin in the suppression of growth hormone secretion by central corticotropin-releasing factor in conscious male rats.

  1985cited by this paper
• Comparative Efficacy of Calcium Antagonist Drugs in the Prophylaxis of Migraine

  1985cited by this paper
• Human cerebrospinal fluid somatostatin in neurologic disease.

  1985cited by this paper
• CSF somatostatin in Alzheimer's disease.

  1984cited by this paper
• Synchronizing, sedative and anticonvulsive effects of centrally administered somatostatin in the conscious rabbit.

  1984cited by this paper
• A Study of Somatostatin Receptors in Amygdaloid‐Kindled Rat Brain

  1984cited by this paper
• Low levels of somatostatin in human CSF mark depressive episodes.

  1984cited by this paper
• Comparative studies with somatostatin and cysteamine in different behavioral tests on rats.

  1984cited by this paper
• Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death

  1984cited by this paper
• Somatostatin-like immunoreactivity in lumbar cerebrospinal fluid from neurohistologically examined demented patients.

  1984cited by this paper
• Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type.

  1984cited by this paper
• Intracerebroventricular somatostatin attenuates electroconvulsive shock-induced amnesia in rats.

  1983cited by this paper
• Cerebrospinal fluid somatostatin in primary affective disorder.

  1983cited by this paper
• Nimodipine, a New Calcium Antagonist, in the Prophylactic Treatment of Migraine

  1983cited by this paper
• Cerebral arterial spasm--a controlled trial of nimodipine in patients with subarachnoid hemorrhage.

  1983cited by this paper
• Effects of somatostatin on mammalian cortical neurons in culture: physiological actions and unusual dose response characteristics

  1983cited by this paper
• The Pharmacology of Calcium Channel Antagonists: a Novel Class of Anti‐migraine Agents?

  1983cited by this paper
• Profound Suppression of Kindled Seizures by Cysteamine: Possible Role of Somatostatin to Kindled Seizures

  1983cited by this paper
• Behavioral effects of nimodipine in animals.

  1982cited by this paper
• Reduced lumbar CSF somatostatin levels in Alzheimer's disease.

  1982cited by this paper
• Low cerebrospinal fluid somatostatin in Parkinson disease

  1982cited by this paper
• Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients.

  1982cited by this paper
• Low somatostatin content in cerebrospinal fluid in multiple sclerosis

  1980cited by this paper
• Central actions of somatostatin.

  1980cited by this paper
• The actions of motilin, luteinizing hormone releasing hormone, cholecystokinin, somatostatin, vasoactive intestinal peptide, and other peptides on rat cerebral cortical neurons.

  1980cited by this paper
• Depressant actions of methionine-enkephalin and somatostatin in cat dorsal horn neurones activated by noxious stimuli.

  1978cited by this paper
• Is somatostatin an excitatory transmitter in the hippocampus?

  1978cited by this paper
• Somatostatin in human cerebrospinal fluid.

  1977cited by this paper
• Depressant action of TRH, LH-RH and somatostatin on activity of central neurones

  1975cited by this paper
• Methods for reliable longitudinal observation of behavior.

  1963cited by this paper

• Differential serum levels of CACNA1C, circadian rhythm and stress response molecules in subjects with bipolar disorder: Associations with genetic and clinical factors.

  2024cites this paper
• Transcriptomic Analysis of the Amygdala in Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder Reveals Differentially Altered Metabolic Pathways.

  2024cites this paper
• Differential Serum Levels of CACNA1C, Circadian Rhythm and Stress Response Molecules in Subjects with Bipolar Disorder: Associations with Genetic and Clinical Factors

  2024cites this paper
• Differentially Altered Metabolic Pathways in the Amygdala of Subjects with Schizophrenia, Bipolar Disorder and Major Depressive Disorder

  2024cites this paper
• Antidepressant-like activity of liposomal formulation containing nimodipine treatment in the tail suspension test, forced swim test and MAOB activity in mice.

  2016cites this paper
• Development and evaluation of liposomal formulation containing nimodipine on anxiolytic activity in mice.

  2014cites this paper
• Antidepressants Influence Somatostatin Levels and Receptor Pharmacology in Brain

  2009cites this paper
• Decreasing procedural pain over time of left prefrontal rTMS for depression: initial results from the open-label phase of a multi-site trial (OPT-TMS).

  2009cites this paper
• Gene expression analysis of bipolar disorder reveals downregulation of the ubiquitin cycle and alterations in synaptic genes

  2006cites this paper
• Dihydropiridines Mechanism of Action in Striatal Isolated Nerve Endings: Comparison with ω-Agatoxin IVA

  2004cites this paper
• 5 Effects of Coffee and Caffeine on Mood and Mood Disorders

  2004cites this paper
• Low CSF somatostatin associated with response to nimodipine in patents with affective illness.

  2003cites this paper
• Neurobiology of Bipolar Illness: Implications for Future Study and Therapeutics

  2003cites this paper
• The Stanley Foundation Bipolar Network

  2001cites this paper
• The use of nimodipine in the treatment of mood disorders.

  2000cites this paper
• Baseline cerebral hypermetabolism associated with carbamazepine response, and hypometabolism with nimodipine response in mood disorders.

  1999cites this paper
• Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain. Gastrointestinal Therapeutic System.

  1998cites this paper
• Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness.

  1998cites this paper
• The Role of Complex Combination Therapy in the Treatment of Refractory Bipolar Illness

  1998cites this paper
• Quality of life and calcium channel blockade with nifedipine GITS versus amlodipine in hypertensive patients in Spain

  1998cites this paper
• Nimodipine in the treatment of dementia.

  1998cites this paper
• The management of coexisting depression in patients with dementia: potential of calcium channel antagonists.

  1997cites this paper